CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOEBT1 who wrote (356)	11/18/1999 6:16:00 PM
From: Dr. John M. de Castro	Read Replies (1) of 666

I just don't buy the company line on this one. "the FDA wanted to do additional analysis on the data. No additional data was requested. Part of the problem was to get the computer data base modified to enable the analysis." I don't care how much data is involved. It doesn't take six months to reformat a data base. Hell, I'm no guru, but I could write a program to transfer any data base to any other format in a few days. There has to be more to the story. The fact that they fired/demoted Tidmarsh speaks of some more serious problems than data formatting. I don't have any insight into their nature. But, I just can't buy IR's explanation of this one. Best regards John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next